FDA Authorizes Pfizer COVID-19 Vaccine for Children 5 to 11
WASHINGTON — The Food and Drug Administration on Friday authorized the Pfizer-BioNTech COVID-19 vaccine for emergency use in children 5 to 11.
“As a mother and a physician, I know that parents, caregivers, school staff, and children have been waiting for today’s authorization,” said Acting FDA Commissioner Dr. Janet Woodcock in a written statement announcing the decision.
“Vaccinating younger children against COVID-19 will bring us closer to returning to a sense of normalcy,” Woodcock continued, adding, “Our comprehensive and rigorous evaluation of the data pertaining to the vaccine’s safety and effectiveness should help assure parents and guardians that this vaccine meets our high standards.”
If the Centers for Disease Control and Prevention signs off, as is expected when its Advisory Committee on Immunization Practices meets next week, children could start getting shots as early as Wednesday.
The FDA said in a press release Friday that children 5 to 11 would be administered a two-dose primary series, three weeks apart, but at a lower dose (10 micrograms) than that used for individuals 12 years of age and older (30 micrograms).
The agency went on to say that in a study involving 3,100 children aged 5 to 11, the immune response was comparable to those in earlier studies on individuals aged 16 to 25. In that study, the vaccine was deemed to be about 90.7% effective.
In addition, the FDA said no serious adverse effects have been detected in the ongoing study.
The Biden administration has promised that children’s shots will be easily accessible at pediatrician offices, community health centers, children’s hospitals and pharmacies, with 15 million doses ready to ship immediately.
States started ordering doses last week, under a formula based on how many children they have in the age group. While the school year is already well underway, the pediatric dose is arriving in time for the holidays, giving more comfort to families looking to gather older and younger people together for the first time since the early months of 2020.
According to the CDC, COVID-19 cases in children 5 to 11 comprise about 39% of cases in individuals younger than 18 years of age.
In addition, the Centers said approximately 8,300 COVID-19 cases in children 5 to 11 resulted in hospitalization.
As of Oct. 17, 691 deaths from COVID-19 have been reported in the U.S. in individuals younger than 18 years of age, with 146 deaths in the 5 to 11 age group, the CDC said.
“Today is a momentous day in the fight against the COVID-19 pandemic, with the FDA’s first emergency use authorization of a coronavirus vaccine for younger children,” House Speaker Nancy Pelosi said in a statement.
“Congress and the country are grateful to our scientists and health officials, who worked quickly and carefully to ensure that the Pfizer vaccine is safe and effective for our youngest Americans,” she said. “Getting our children vaccinated is the best way to ensure their health and safety, so they can go to school, spend time with their families and engage in our communities with the confidence of knowing they are protected from this vicious virus.
“It is heartbreaking that more than a thousand Americans lose their lives to this virus each day, nearly all of whom were unvaccinated. It is now crucial that every eligible American — especially children ages five to eleven — get vaccinated as quickly as possible, so that we can finally put an end to this pandemic,” Pelosi added.
Dan can be reached at [email protected] and at https://twitter.com/DanMcCue
In The News
WASHINGTON — The lead Senate sponsors of the PFAS Free Military Purchasing Act this week lauded the Department of Defense’s... Read More
WASHINGTON — The lead Senate sponsors of the PFAS Free Military Purchasing Act this week lauded the Department of Defense’s recent decision to make its own stand against the proliferation of so-called “forever chemicals.” Late last month, the Defense Department issued a Defense Federal Acquisition Regulation... Read More
WASHINGTON — According to the Centers for Disease Control and Prevention, nearly seven in 10 adults between the ages of... Read More
WASHINGTON — According to the Centers for Disease Control and Prevention, nearly seven in 10 adults between the ages of 40 and 79 used at least one prescription drug in the past 30 days in the United States, and approximately one in five used at least... Read More
WASHINGTON — The National Institutes of Health has awarded 103 new research grants, totaling some $285 million, to support highly... Read More
WASHINGTON — The National Institutes of Health has awarded 103 new research grants, totaling some $285 million, to support highly innovative scientists who propose visionary and broadly impactful meritorious behavioral and biomedical research projects. The 2022 NIH Director’s Awards are bestowed through the institute’s High-Risk, High-Reward... Read More
WASHINGTON — Despite the results of a previous study, sildenafil (Viagra) and tadalafil (Cialis) may not be suitable candidates for... Read More
WASHINGTON — Despite the results of a previous study, sildenafil (Viagra) and tadalafil (Cialis) may not be suitable candidates for treating dementia, according to the National Institutes of Health. The institute recently delved into the situation with its Drug Repurposing for Effective Alzheimer's Medicines study. In... Read More
ATLANTA — Doctors should be on the lookout for a possible increase in enterovirus D68, a respiratory infection that may... Read More
ATLANTA — Doctors should be on the lookout for a possible increase in enterovirus D68, a respiratory infection that may be linked to more cases of the rare, paralyzing condition acute flaccid myelitis, the Centers for Disease Control and Prevention said last week. The CDC has... Read More
PORTLAND, Ore. — The cochlea in the inner ear detects low-frequency sound in a manner very different than previously known,... Read More
PORTLAND, Ore. — The cochlea in the inner ear detects low-frequency sound in a manner very different than previously known, a discovery that may make it possible to design better cochlear implants for people with hearing impairments. The finding is the result of research from scientists... Read More